Risk for Metachronous Advanced Neoplasia in Patients With a Modified Definition of Advanced Adenoma: Data From the New Hampshire Colonoscopy Registry

根据改良的高级腺瘤定义,新罕布什尔州结肠镜检查登记处的数据表明,患者发生异时性高级肿瘤的风险较高。

阅读:3

Abstract

BACKGROUND & AIMS: The term "advanced adenoma" (AA) includes adenomas ≥1 cm, ones with villous histology or high-grade dysplasia (HGD), or polyps that may be heterogeneous for metachronous advanced neoplasia (AN) risk (AA and adenocarcinoma). We compared risk in individuals with 10- to 19-mm tubular adenomas (TAs) vs those with HGD, villous histology, and TAs ≥20 mm (modified AAs). METHODS: We used the New Hampshire Colonoscopy Registry to identify individuals having index colonoscopies and follow-up exams 12 months or longer. Outcomes were metachronous AN and subsequent colorectal cancer (CRC). Using Poisson loglinear and Cox proportional hazards models, we compared adjusted metachronous risk of AA and CRC between the 2 AA subgroups and those with lesser findings. RESULTS: There were 35,941 adults stratified by index findings: Group 1: no adenomas (n = 20,857); Group 2: 1 to 2 small (<1 cm) TAs (n = 9927); Group 3: 3 to 10 small (<1 cm) TAs (n = 2124); Group 4: 10- to 19-mm TAs (n = 1492), and the modified AA group (Group 5) (n = 1541). Compared with Groups 1 to 3, Group 4 (rate ratio [RR], 3.67; 95% confidence interval [CI], 2.99-4.50) and Group 5 (RR, 4.69; 95% CI, 3.82-5.77) had higher adjusted AN risk, with overlapping 95% CIs. However, when using the modified AA definition as an outcome, we observed that the modified AA group had a statistically significantly higher risk for metachronous modified AA than the large (10-19 mm) TA group (RR, 1.52; 95% CI, 1.04-2.22). Compared with the low-risk groups (Groups 1-3), Group 4 (hazard ratio [HR], 2.44; 95% CI, 1.34-4.44) and Group 5 (HR, 3.52; 95% CI, 1.98-6.25) had higher HRs for CRC with overlapping CIs. CONCLUSIONS: The modified AA groups had a statistically higher risk of a modified AN outcome and a numerically higher CRC risk than the 10- to 19-mm TA group. Future studies should validate these findings and extend them by examining differences in metachronous risk within the 10- to 19-mm TA group.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。